Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway

BACKGROUND: The present study aimed to evaluate the suppressive role of interleukin (IL)-25 in IL-22-induced osteoclastogenesis and receptor activator of nuclear factor κB ligand (RANKL) expression in rheumatoid arthritis (RA). METHODS: Serum from patients with RA and osteoarthritis (OA), and health...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Min, Hong Ki, Won, Ji-Yeon, Kim, Bo-Mi, Lee, Kyung-Ann, Lee, Seoung-Joon, Lee, Sang-Heon, Kim, Hae-Rim, Kim, Kyoung-Woon
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7517649/
https://ncbi.nlm.nih.gov/pubmed/32972460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02315-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados